The foundation stone of the Blood Purification Industrial Base and R&D Center of Biolight Group was officially laid on November 20, 2020, and with the strong support of all participating units, it welcomed the capping. In the salute and thunderous applause, the leading guests who participated in the topping out ceremony jointly picked up the shovels in their hands and poured the last concrete on the roof of the main building of the base, so that the topping out ceremony of the Blood Purification Industrial Base and R&D Center of the Biolight Group was a complete success. The Blood Purification Industrial Base and R&D Center of Biolight Group will be completed and put into operation in 2023. Yan Jinyuan, Chairman of Biolight Group, said in his speech at the scene: "In 2023, Biolight will celebrate its 30th anniversary, and will also usher in the completion of the blood purification industry base and R&D Center, which marks that Biolight is about to take off and enter a new milestone! ”

   The Blood Purification Industrial Base and R&D Center of Biolight Group are located in Zhuhai High-tech Zone, with a total investment of 500 million yuan and a total construction area of more than 60,000 square meters. After the completion of the base, it will mainly carry out the production and manufacturing of hemodialysis equipment and consumables. After the base is put into operation, it will adopt scientific functional area division and build a mature industrial system with efficient output, helping Biolight usher in a new round of production capacity explosion, achieving an annual output of 4 million blood dialysate, 500,000 dialysate filters (endotoxin filters), 20 million dialyzers, and 2,000 blood purification equipment.

   At the same time, the base will build a Blood Purification R&D Center, introduce top-notch R&D talents to the world, and strive to promote core technology breakthroughs, further improve product performance and stability, and gradually realize the import substitution of blood purification equipment and consumables. Standing at the forefront of the times and industry development, Biolight unswervingly puts customer needs first, develops more advantageous products and shapes a first-class service team, and constantly improves its core competitiveness.

   In the future, Biolight Group will rely on the new industrial base, continue to enhance R&D strength, promote high-speed and high-quality development, show the new responsibilities and new actions of the enterprise, continue to help the development of the national medical device industry, and realize the beautiful vision of "national industry international brand".